Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Mercado Continuo Espanol  >  Grifols SA       ES0171996012

 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials (€)
Sales 2016 4 129 M
EBIT 2016 1 047 M
Net income 2016 574 M
Debt 2016 3 430 M
Yield 2016 1,76%
Sales 2017 4 280 M
EBIT 2017 1 116 M
Net income 2017 666 M
Debt 2017 3 114 M
Yield 2017 1,95%
P/E ratio 2016 23,36
P/E ratio 2017 20,12
EV / Sales 2016 3,78x
EV / Sales 2017 3,58x
Capitalization 12 190 M
More Financials
Company
Grifols SA is a vertically integrated global producer of plasma derivatives.Its activities include sourcing raw material, manufacturing various plasma derivative products and selling and distributing final products to healthcare providers.The company operates through four segments: Bioessence,... 
Sector
Pharmaceuticals
Calendar
05/27 | 12:00pmShareholder meeting
More about the company
Surperformance© ratings of Grifols SA
Trading Rating : Investor Rating :
More Ratings
Latest news on GRIFOLS SA
05/27 GRIFOLS : allocates EUR 213 million to dividends and maintains pay-out at 40% of..
05/27 GRIFOLS : allocates EUR 213 million to dividends and maintains pay-out at 40% of..
05/19 ARADIGM : Announces First Quarter 2016 Financial Results
05/05 GRIFOLS' : revenues increase by +5.6% to Euros 959 million, driven by growth of ..
05/05 GRIFOLS' : revenues increase by +5.6% to Euros 959 million, driven by growth of ..
05/05 GRIFOLS' : revenues increase by +5.6% to Euros 959 million, driven by growth of ..
04/22 GRIFOLS : dedicates green building
04/18 GRIFOLS : The Catalan Down's Syndrome Foundation and Grifols are working togethe..
04/18 GRIFOLS : The Catalan Down's Syndrome Foundation and Grifols are working togethe..
03/23 GRIFOLS : Therapeutics Assigned Patent
More news
Sector news : Biopharmaceuticals
05/27 ASTRAZENECA : Faslodex demonstrates superiority to Arimidex in Phase III study
05/27 MARKETS RIGHT NOW : Stocks close higher on Wall Street
05/27 DR REDDY LABORATORIES : Merger and Acquisition Round Up – May 23 to 27, 20..
05/27 SANOFI : eyeing manufacturing expansion
05/27 Levi & Korsinsky, LLP Announces the Commencement of an Investigation Into Pos..
More sector news : Biopharmaceuticals
News from SeekingAlpha
01/04 Midday Gainers / Losers
2015 Tracking John Paulson's Paulson & Company Portfolio - Q3 2015 Update
2015 TiGenix Achieves First Ever Success In Allogeneic Stem Cell Phase 3 Trial
2015 Tracking John Paulson's Paulson & Company Portfolio - Q2 2015 Update
2015 Tracking John Paulson's Paulson & Company Portfolio - Q1 2015 Update
Advertisement
Chart GRIFOLS SA
Duration : Period :
Grifols SA Technical Analysis Chart | ES0171996012 | 4-Traders
Full-screen chart
Technical analysis trends GRIFOLS SA
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions